BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 1967440)

  • 21. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.
    Bingley PJ
    Diabetes; 1996 Dec; 45(12):1720-8. PubMed ID: 8922357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.
    Harrison LC; Chu SX; DeAizpurua HJ; Graham M; Honeyman MC; Colman PG
    J Clin Invest; 1992 Apr; 89(4):1161-5. PubMed ID: 1556180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of progression to diabetes of low titer ICA-positive first-degree relatives of type I diabetics in southern Germany.
    Ziegler AG; Baumgartl HJ; Standl E; Mehnert H
    J Autoimmun; 1990 Oct; 3(5):619-24. PubMed ID: 2252530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM.
    Rabinowe SL; Brown FM; Watts M; Kadrofske MM; Vinik AI
    Diabetes Care; 1989 Jan; 12(1):1-6. PubMed ID: 2653745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
    Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM.
    Samuelsson U; Ludvigsson J; Sundkvist G
    Diabetes Res Clin Pract; 1994 Dec; 26(3):155-62. PubMed ID: 7736895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting insulin-dependent diabetes.
    Tarn AC; Thomas JM; Dean BM; Ingram D; Schwarz G; Bottazzo GF; Gale EA
    Lancet; 1988 Apr; 1(8590):845-50. PubMed ID: 2895363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies.
    Martino GV; Tappaz ML; Braghi S; Dozio N; Canal N; Pozza G; Bottazzo GF; Grimaldi LM; Bosi E
    J Autoimmun; 1991 Dec; 4(6):915-23. PubMed ID: 1812896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Islet cell antibodies in normal French schoolchildren.
    Lévy-Marchal C; Tichet J; Fajardy I; Gu XF; Dubois F; Czernichow P
    Diabetologia; 1992 Jun; 35(6):577-82. PubMed ID: 1612232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
    Roll U; Christie MR; Standl E; Ziegler AG
    Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins.
    Christie MR; Roll U; Payton MA; Hatfield EC; Ziegler AG
    Diabetes Care; 1997 Jun; 20(6):965-70. PubMed ID: 9167107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients.
    Thivolet C; Beaufrère B; Geburher L; Chatelain P; Orgiazzi J; François R
    Diabetologia; 1991 Mar; 34(3):186-91. PubMed ID: 1884891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Islet cell antibodies and beta-cell function in gestational diabetic women: comparison to first-degree relatives of type 1 (insulin-dependent) diabetic subjects.
    Mauricio D; Corcoy R; Codina M; Morales J; Balsells M; de Leiva A
    Diabet Med; 1995 Nov; 12(11):1009-14. PubMed ID: 8582122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
    Wiest-Ladenburger U; Hartmann R; Hartmann U; Berling K; Böhm BO; Richter W
    Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.
    Kuglin B; Bertrams J; Linke C; Gries FA; Kolb H
    Klin Wochenschr; 1989 Jan; 67(2):66-73. PubMed ID: 2646470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop.
    Greenbaum CJ; Palmer JP; Nagataki S; Yamaguchi Y; Molenaar JL; Van Beers WA; MacLaren NK; Lernmark A
    Diabetes; 1992 Dec; 41(12):1570-4. PubMed ID: 1446798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.